Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Oncternal Therapeutics Inc (ONCT)

Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board Business Wire - Tue Jun 23, 7:30AM CDT

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today...

ACOG : 9.16 (-5.91%)
ONCT : 0.5266 (-24.11%)
CBAY : 32.48 (+0.03%)
MIST : 1.1600 (-2.52%)
Oncternal Therapeutics Announces the Sale of Select Development Programs and the Wind-Down of its Operations GlobeNewswire - Tue Jul 1, 2025

ONCT : 0.5266 (-24.11%)
Oncternal Therapeutics Announces the Sale of Select Development Programs and the Wind-Down of its Operations GlobeNewswire - Tue Jul 1, 2025

SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. today announced the sale of its zilovertamab and ONCT-808 programs to Ho’ola...

ONCT : 0.5266 (-24.11%)
Oncternal Therapeutics Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC GlobeNewswire - Fri Mar 7, 2025

ONCT : 0.5266 (-24.11%)
Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer GlobeNewswire - Tue Oct 22, 2024

ONCT : 0.5266 (-24.11%)
Oncternal Therapeutics: Q2 Earnings Snapshot AP - Thu Aug 8, 2024

Oncternal Therapeutics: Q2 Earnings Snapshot

ONCT : 0.5266 (-24.11%)
Wall Street - NYSE Stock Market American Flag
Stocks Climb Before the Open as Investors Weigh Economic Outlook, U.S. JOLTs Report in Focus Barchart - Tue Apr 4, 2023

June S&P 500 futures (ESM23) are up +0.29%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.61% this morning after three major U.S. benchmark indices finished the regular session mixed as weaker-than-expected...

VORB : 0.0769 (-34.83%)
ESM23 : 4,453.35s (+0.61%)
TSLA : 348.75 (-1.71%)
ONCT : 0.5266 (-24.11%)
AMC : 2.59 (-4.07%)
NQM23 : 15,316.61s (+0.85%)
HLN : 10.11 (+0.70%)
CRBG : 32.61 (-0.06%)
OKYO.LN : 1.400 (-24.32%)
BFLY : 8.43 (-3.33%)
EVO : 1.9100 (-3.05%)

Barchart Exclusives

Tesla Just Killed Its Solar Roof After Years of Struggling to Scale. What It Means for TSLA Stock. Barchart - Sun Aug 30, 5:05PM CDT
Tesla is ending Solar Roof sales after years of limited adoption while shifting its solar strategy toward conventional panels and energy storage. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.